2002
DOI: 10.1385/bmm:1:1:51
|View full text |Cite
|
Sign up to set email alerts
|

Hypercalcemia of Malignancy: Epidemiology and Pathogenesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
5
0

Year Published

2003
2003
2017
2017

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 70 publications
2
5
0
Order By: Relevance
“…6 PHRP was extracted from various malignant tumors and increased blood levels of PHRP were demonstrated in patients with malignant tumors associated with humoral hypercalcemia. 1 In our case, the immunohistochemical demonstration of PHRP in the tumor provided conclusive evidence that PHRP secretion by the tumor accounted for the hypercalcemia. The tumor consisted of two parts: a squamous cell and a pleomorphic small cell component.…”
Section: Discussionsupporting
confidence: 65%
See 4 more Smart Citations
“…6 PHRP was extracted from various malignant tumors and increased blood levels of PHRP were demonstrated in patients with malignant tumors associated with humoral hypercalcemia. 1 In our case, the immunohistochemical demonstration of PHRP in the tumor provided conclusive evidence that PHRP secretion by the tumor accounted for the hypercalcemia. The tumor consisted of two parts: a squamous cell and a pleomorphic small cell component.…”
Section: Discussionsupporting
confidence: 65%
“…It was an intriguing finding that PHRP immunoreactivity was apparent only in the pleomorphic small cell component and not in the squamous epithelial cells. It is known that PHRP is expressed in the stratum spinosum of the normal epidermis and in many squamous cell carcinomas 1 . Thus, it was an unexpected observation that in our case, PHRP immunopositivity was detected only in the pleomorphic small cell component and not in the squamous cells of the tumor.…”
Section: Discussionsupporting
confidence: 46%
See 3 more Smart Citations